Skip to Content
Jump to the top of the page

Showing 1170 – 1180 of 1304 results

  • Latham Group Inc Initiation

    William Blair initiated research coverage of Latham Group, Inc. (SWIM $32.70), the leading manufacturer of residential in-ground pools in North America. It also sells pool components and accessories in North America, Australia, and New Zealand.

  • MaxCyte Inc Initiation

    William Blair initiated research coverage of MaxCyte, Inc. (MXCT $14.34), a market-leading provider of enabling technologies for cell engineering. The company’s ExPERT platform is used to advance the discovery, development, and commercialization of next-generation cell therapies.

  • thredUP Inc Initiation

    William Blair initiated research coverage of thredUP, Inc. (TDUP $14.98). ThredUP facilitates the sale of secondhand apparel and accessories through its digital marketplace and resale-as-a-service partnerships using its proprietary single-SKU supply chain network to enable sellers to reach a broader group of buyers.

  • Ikena Oncology Inc Initiation

    William Blair initiated research coverage of Ikena Oncology, Inc. (IKNA $17.99). Based in Boston, Ikena is developing a pipeline of targeted oncology therapies for novel disease targets, including IK-930, a Hippo pathway inhibitor, which is potentially relevant in up to 10% of all cancers.

  • Alignment Healthcare Inc Initiation

    William Blair initiated research coverage of Alignment Healthcare, Inc. (ALHC $26.06), an emerging, technology-enabled Medicare Advantage (MA) plan operator. The company’s mission is to leverage a robust and proprietary IT platform to promote more-efficient, highly coordinated, and lower-cost care for seniors, with the mission of improving healthcare, “one senior at a time.”

  • Praxis Precision Medicines Inc Initiation

    William Blair initiated research coverage of Praxis Precision Medicines, Inc. (PRAX $30.04), a clinical-stage biopharmaceutical company translating genetic insights into novel therapies for the treatment of central nervous system disorders.

  • Torrid Holdings Inc Initiation

    William Blair initiated research coverage of Torrid Holdings Inc. (CURV $22.73). Torrid is a fast-growing, omnichannel retailer of apparel, intimates, and accessories dedicated to plus-size women, offering mostly exclusive brands and in-house designs with a particular focus on fit.

  • Sera Prognostics Inc Initiation

    William Blair initiated research coverage of Sera Prognostics, Inc. (SERA $12.85), a women’s health diagnostics company that discovers, develops, and commercializes biomarker tests using a proprietary proteomics and bioinformatics platform. The company’s initial focus is on improving pregnancy outcomes, beginning with preterm birth (PTB).

  • Oatly Group AB Initiation

    William Blair initiated research coverage of Oatly Group AB (OTLY $26.41). Oatly is the world’s original and largest oat milk company with technical expertise in oats and oat-based dairy alternatives and a vision for a food system that is better for people and the planet.

  • TaskUs, Inc. Initiation

    William Blair initiated research coverage of TaskUs, Inc. (TASK $33.24). TaskUs is a next-generation digital customer experience (CX) service provider specializing in high-growth services including digital CX, content moderation, and AI operations.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures